These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16115623)

  • 1. Inhibition of the osteoclast V-ATPase by small interfering RNAs.
    Hu Y; Nyman J; Muhonen P; Väänänen HK; Laitala-Leinonen T
    FEBS Lett; 2005 Sep; 579(22):4937-42. PubMed ID: 16115623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rationale for osteoclast selectivity of inhibiting the lysosomal V-ATPase a3 isoform.
    Nyman JK; Väänänen HK
    Calcif Tissue Int; 2010 Sep; 87(3):273-83. PubMed ID: 20596699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin inhibition of V-ATPase a3-d2 interaction decreases osteoclast resorptive activity.
    Crasto GJ; Kartner N; Yao Y; Li K; Bullock L; Datti A; Manolson MF
    J Cell Biochem; 2013 Apr; 114(4):929-41. PubMed ID: 23129004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump.
    Lu X; Qin W; Li J; Tan N; Pan D; Zhang H; Xie L; Yao G; Shu H; Yao M; Wan D; Gu J; Yang S
    Cancer Res; 2005 Aug; 65(15):6843-9. PubMed ID: 16061667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of proton pumps in osteoclasts: V-ATPase with a3 and d2 isoforms is a major form in osteoclasts.
    Matsumoto N; Daido S; Sun-Wada GH; Wada Y; Futai M; Nakanishi-Matsui M
    Biochim Biophys Acta; 2014 Jun; 1837(6):744-9. PubMed ID: 24561225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vacuolar H+-ATPase d2 subunit: molecular characterization, developmental regulation, and localization to specialized proton pumps in kidney and bone.
    Smith AN; Jouret F; Bord S; Borthwick KJ; Al-Lamki RS; Wagner CA; Ireland DC; Cormier-Daire V; Frattini A; Villa A; Kornak U; Devuyst O; Karet FE
    J Am Soc Nephrol; 2005 May; 16(5):1245-56. PubMed ID: 15800125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional complementation of V-ATPase a subunit isoforms in osteoclasts.
    Matsumoto N; Sekiya M; Fujimoto Y; Haga S; Sun-Wada GH; Wada Y; Nakanishi-Matsui M
    J Biochem; 2021 Apr; 169(4):459-466. PubMed ID: 33135054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iejimalides show anti-osteoclast activity via V-ATPase inhibition.
    Kazami S; Muroi M; Kawatani M; Kubota T; Usui T; Kobayashi J; Osada H
    Biosci Biotechnol Biochem; 2006 Jun; 70(6):1364-70. PubMed ID: 16794315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of V-ATPases in osteoclasts: potential therapeutic targets for the treatment of osteolysis.
    Xu J; Cheng T; Feng HT; Pavlos NJ; Zheng MH
    Histol Histopathol; 2007 Apr; 22(4):443-54. PubMed ID: 17290355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis.
    Duan X; Yang S; Zhang L; Yang T
    Theranostics; 2018; 8(19):5379-5399. PubMed ID: 30555553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic identification of the TRAF6 regulation of vacuolar ATPase for osteoclast function.
    Ryu J; Kim H; Lee SK; Chang EJ; Kim HJ; Kim HH
    Proteomics; 2005 Nov; 5(16):4152-60. PubMed ID: 16196101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The R740S mutation in the V-ATPase a3 subunit results in osteoclast apoptosis and defective early-stage autophagy.
    Ochotny N; Voronov I; Owen C; Aubin JE; Manolson MF
    J Cell Biochem; 2013 Dec; 114(12):2823-33. PubMed ID: 23908015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption.
    Qin A; Cheng TS; Pavlos NJ; Lin Z; Dai KR; Zheng MH
    Int J Biochem Cell Biol; 2012 Sep; 44(9):1422-35. PubMed ID: 22652318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of osteoclast bone resorption by disrupting vacuolar H+-ATPase a3-B2 subunit interaction.
    Kartner N; Yao Y; Li K; Crasto GJ; Datti A; Manolson MF
    J Biol Chem; 2010 Nov; 285(48):37476-90. PubMed ID: 20837476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase.
    Laitala T; Väänänen HK
    J Clin Invest; 1994 Jun; 93(6):2311-8. PubMed ID: 8200964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The R740S mutation in the V-ATPase a3 subunit increases lysosomal pH, impairs NFATc1 translocation, and decreases in vitro osteoclastogenesis.
    Voronov I; Ochotny N; Jaumouillé V; Owen C; Manolson MF; Aubin JE
    J Bone Miner Res; 2013 Jan; 28(1):108-18. PubMed ID: 22865292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.
    Niikura K; Takano M; Sawada M
    Br J Pharmacol; 2004 Jun; 142(3):558-66. PubMed ID: 15148249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption.
    Wu H; Xu G; Li YP
    J Bone Miner Res; 2009 May; 24(5):871-85. PubMed ID: 19113919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of human a3 and a4 mutations that result in osteopetrosis and distal renal tubular acidosis on yeast V-ATPase expression and activity.
    Ochotny N; Van Vliet A; Chan N; Yao Y; Morel M; Kartner N; von Schroeder HP; Heersche JN; Manolson MF
    J Biol Chem; 2006 Sep; 281(36):26102-11. PubMed ID: 16840787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct expression patterns of different subunit isoforms of the V-ATPase in the rat epididymis.
    Pietrement C; Sun-Wada GH; Silva ND; McKee M; Marshansky V; Brown D; Futai M; Breton S
    Biol Reprod; 2006 Jan; 74(1):185-94. PubMed ID: 16192400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.